SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001655759-23-000028
Filing Date
2023-03-10
Accepted
2023-03-10 15:56:42
Documents
12
Period of Report
2023-03-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K arvn-20230310.htm   iXBRL 8-K 35739
  Complete submission text file 0001655759-23-000028.txt   175392

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arvn-20230310.xsd EX-101.SCH 1899
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arvn-20230310_lab.xml EX-101.LAB 24849
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arvn-20230310_pre.xml EX-101.PRE 13044
6 EXTRACTED XBRL INSTANCE DOCUMENT arvn-20230310_htm.xml XML 11886
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38672 | Film No.: 23723492
SIC: 2834 Pharmaceutical Preparations